Noncancer Cells in Tumor Samples May Bias the Predictive Genomic-Adjusted Radiation Dose

We have read with interest the article by Scott et al.1Scott J.G. Sedor G. Scarborough J.A. et al.Personalizing radiotherapy prescription dose using genomic markers of radiosensitivity and normal tissue toxicity in non-small cell lung cancer [e-pun ahead of print]. J Thorac Oncol.https://doi.org/10.1016/j.jtho.2020.11.008Google Scholar In this article, the authors developed the genomic-adjusted radiation dose (GARD), a mathematical method to...